Sign in

NCT05120492Recruiting

Optimal Management of Extreme Obesity and Severe Knee Osteoarthritis Feasibility Trial

Source: ClinicalTrials.gov · Last updated 21 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Does weight loss surgery in patients with morbid obesity prior to knee replacement surgery improve outcomes from knee replacement surgery

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
3 Nov 2021
Start date
22 Apr 2022
Primary completion date
Jul 2027
Lead sponsor
Nova Scotia Health Authority
Diseases
Obesity
NCT number
NCT05120492

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 22 Apr 2022 to the primary completion date, Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous total replacement of the same knee, a need for bilateral total knee replacement, and knee pain during the previous week that the patient rated at higher than 60 mm on a 100-mm visual-analogue scale. Also,prior bariatric or complex foregut surgery, significant cardiovascular, pulmonary, renal, liver, gastrointestinal, psychiatric disorders, pregnancy, malignancy within last 5 years, anemia, coagulopathy requiring anti-coagulation therapy.

Who the study is looking for

  • severe knee osteoarthritis body-mass index of 45 to 60

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Nova Scotia Health
Coordinator of this site? Confirm its status
HalifaxCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.